bifendate has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, S; Han, J; Jin, S; Lu, Y; Lv, Q; Qi, J; Wu, W; Yuan, H | 1 |
| Dong, H; Feng, XD; Geng, W; Han, YF; Ko, KM; Li, N; Pan, SY; Yang, R | 1 |
| Dong, H; Ko, KM; Pan, SY; Yang, R; Yu, ZL | 1 |
| Mahfoz, AM | 1 |
| Jiang, Z; Liu, F; Meng, H; Shi, Y; Yu, Y; Zhou, Q | 1 |
| Dai, C; Hao, H; Kang, A; Li, J; Liang, Y; Sun, S; Wang, G; Xie, L; Xie, T; Xie, Y; Zheng, X | 1 |
| El-Bahy, AA; Heikal, OA; Kassem, LA; Mahran, LG | 1 |
| Abdelbary, GA; Aburahma, MH | 1 |
| Li, Y; Lu, H | 1 |
| Li, Y | 1 |
| el-Bahrawy, HA; el-Sawy, SA; el-Shafey, AM | 1 |
| Gao, M; Liu, G; Zhang, J | 1 |
12 other study(ies) available for bifendate and Disease Models, Animal
| Article | Year |
|---|---|
Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.
Topics: Administration, Oral; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Biological Availability; Biphenyl Compounds; Carbon Tetrachloride; Deoxycholic Acid; Disease Models, Animal; Drug Stability; Glycyrrhizic Acid; Liver; Male; Micelles; Nanoconjugates; Particle Size; Phospholipids; Rats; Rats, Wistar; Surface Properties | 2012 |
High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins B; Biphenyl Compounds; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred ICR; Rabbits; Triglycerides | 2006 |
Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.
Topics: Animals; Bile Acids and Salts; Biphenyl Compounds; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Fenofibrate; Hypercholesterolemia; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Time Factors; Triglycerides | 2006 |
Social behavior effects of diphenyl dimethyl bicarboxylate (DDB) in the sensory contact model.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bone Marrow Cells; Brain; Depression; Dioxoles; Disease Models, Animal; Dopamine; Immunologic Factors; Leukocyte Count; Male; Mice; Norepinephrine; Serotonin; Social Behavior | 2019 |
[Effects of amantadine and biphenyl dimethyl dicarboxylate on hepatitis B virus in hepatitis B virus replication mice].
Topics: Amantadine; Animals; Antiviral Agents; Dioxoles; Disease Models, Animal; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Male; Mice; Mice, Inbred BALB C; Plasmids; Transfection; Virus Replication | 2014 |
Integral pharmacokinetics of multiple lignan components in normal, CCl4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers.
Topics: Alanine Transaminase; Animals; Area Under Curve; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP3A; Dioxoles; Disease Models, Animal; Down-Regulation; Female; Fruit; Herb-Drug Interactions; Lignans; Male; Phytotherapy; Plant Extracts; Protective Agents; Rats; Rats, Sprague-Dawley; Reference Values; Schisandra | 2010 |
Antiapoptotic effect of DDB against hepatic ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Biomarkers; Dioxoles; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Hepatocytes; Ischemic Preconditioning; Liver; Liver Function Tests; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2011 |
Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Calorimetry, Differential Scanning; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chemistry, Pharmaceutical; Dioxoles; Disease Models, Animal; Drug Compounding; Liposomes; Liver; Male; Microscopy, Electron, Transmission; Particle Size; Polysorbates; Powder Diffraction; Powders; Rats; Rats, Wistar; Rheology; Solubility; Sorbitol; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Time Factors; Water; X-Ray Diffraction | 2012 |
Effects of dimethyl diphenyl bicarboxylate on the metabolism and hepatotoxicity of aflatoxin B1 in rats.
Topics: Aflatoxin B1; Aflatoxin M1; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Dioxoles; Disease Models, Animal; Male; Microsomes, Liver; Protective Agents; Rats | 2002 |
[Effect of dimethyl diphenyl bicarboxylate (DDB) on 9-amino-1,2,3,4-tetrahydroacridine-induced hepatotoxicity in mice].
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP1A1; Dioxoles; Disease Models, Animal; Male; Mice; Microsomes, Liver; Protective Agents; Random Allocation; Rats; Rats, Wistar; Tacrine | 2001 |
Effect of dimethyl diphenyl bicarboxylate on normal and chemically-injured liver.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Dioxoles; Disease Models, Animal; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Liver; Liver Diseases; Liver Function Tests; Male; Malondialdehyde; Rats; Time Factors | 2002 |
Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
Topics: Adjuvants, Immunologic; Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Dioxoles; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gene Expression; Hepatitis, Animal; Hepatocytes; Liver; Liver Function Tests; Male; Mice; Mice, Inbred ICR; Protective Agents; RNA, Messenger; Tumor Necrosis Factor-alpha | 2005 |